Immunosuppressive treatment for focal segmental glomerulosclerosis in adults (Q24242266)

focal segmental glomerulosclerosis

Europe PubMed Central

title

Immunosuppressive treatment for focal segmental glomerulosclerosis in adults (English)

0 references

main subject

1 reference

Giuseppe Remuzzi

5

0 references

Annalisa Perna

4

object named as

Annalisa Perna

0 references

author name string

Norbert Braun

1

0 references

Frank Schmutzler

2

0 references

Catalina Lange

3

0 references

Narelle S Willis

Cochrane Database of Systematic Reviews

6

0 references

publication date

16 July 2008

0 references

published in

0 references

cites work

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Therapy of the idiopathic nephrotic syndrome with alternate day steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Ciclosporin in the treatment of nephrosis. Minimal change disease and focal-segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Therapy of idiopathic nephrotic syndrome in adults. A conservative or aggressive therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Treatment of primary focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003233.PUB2

Management of focal segmental glomerulosclerosis: evidence-based recommendations.

21 January 2018

1 reference

12 December 2020

Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly.

1 reference

12 December 2020

Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie

1 reference

12 December 2020

Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up

1 reference

12 December 2020

Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome

1 reference

12 December 2020

The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study

1 reference

12 December 2020

Focal segmental glomerulosclerosis in adult African Americans

1 reference

12 December 2020

Long-term cyclosporin A treatment in adults with refractory nephrotic syndrome

1 reference

12 December 2020

Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis

1 reference

12 December 2020

Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment

1 reference

12 December 2020

Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis

1 reference

12 December 2020

Focal sclerosing glomerulopathy risk factors of progression and optimal mode of treatment

1 reference

12 December 2020

Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome

1 reference

12 December 2020

Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis

1 reference

12 December 2020

Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis

1 reference

12 December 2020

[Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results]

1 reference

12 December 2020

Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types

1 reference

12 December 2020

The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.

1 reference

12 December 2020

Prednisone/cyclophosphamide treatment in adult-onset autosomal dominant familial focal segmental glomerulosclerosis (FSGS 1)

1 reference

12 December 2020

Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A

1 reference

12 December 2020

Focal segmental glomerulosclerosis in African Americans: effects of steroids and angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study

1 reference

12 December 2020

Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study

1 reference

12 December 2020

Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children

1 reference

12 December 2020